In the present study, we therefore immunolocalized DDR2 and collagen type I in 224 invasive breast carcinoma tissues to clarify the biological and/or clinical significance and subsequently conducted in vitro studies to confirm the role of DDR2 in breast cancer chemoresistance using both chemosensitive and chemoresistant cell lines. Here, DDR2 is linked to breast carcinoma.